Endocrinology
Hello, Suzanne Dixon
Manage E-mail  |  Logout

Article ID

Home
General Endocrinology
Messages (38)
Conferences
Jobs
Newsletters
My Library
Topics in
Endocrinology
        Adrenal Glands
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Bone Metabolism
        Diabetes
        Diagnostics
        Economics of Medicine
        Endocrine Oncology
        Fetal Development
        Hypertension
        Metabolism and Growth
        Neuroendocrinology
        Obesity
        Pediatric Endocrinology
        Pharmacology/kinetics
        Popular Press
        Reproductive
    Endocrinology
        Thyroid/Parathyroid
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

Need hemophilia CME? Here’s the latest, straight from ISTH 2009 in Boston, with expert commentary on the topics you...
Victoria Luken, MDLinx CME
FDA Update: Bevacizumab + Interferon Alfa Approved for Renal Cell Carcinoma
Tracy Hampton, PhD, MDLinx Oncology
Congress Proposes SGR Fix
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all

Articles: Pharmacology/kinetics



Latest (1) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


A1c Control in a Primary Care Setting: Self-titrating an Insulin Analog Pre-mix (INITIATEplus Trial)
American Journal of Medicine, 10/27/09
Sponsor
Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet - Early Online Publication, 10/23/09
Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
Current Medical Research and Opinion, 10/22/09
Exclusive Author Commentary
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150mg and risedronate 150mg
Current Medical Research and Opinion, 10/22/09    Revew Article
Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study
Journal of Clinical Endocrinology and Metabolism, 10/21/09
Nocturnal Blood Glucose and IGFBP-1 Changes in Type 1 Diabetes: Differences in the Dawn Phenomenon between Insulin Regimens
Experimental and Clinical Endocrinology & Diabetes, 10/21/09
Effects of Exenatide Alone and in Combination with Daclizumab on Beta Cell Function in Long-Standing Type 1 Diabetes Mellitus
Diabetes Care, 10/20/09
Many Americans Have Prediabetes and Should Be Considered for Metformin Therapy
Diabetes Care, 10/20/09
Dapagliflozin: where does it fit in the treatment of type 2 diabetes
Expert Opinion in Pharmacotherapy, 10/19/09
Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement
International Journal of Clinical Practice, 10/19/09    Clinical Guideline
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
Cochrane Reviews, 10/19/09    Revew Article
A Comparison of the Handling and Accuracy of Syringe and Vial Versus Prefilled Insulin Pen (FlexPen)
Diabetes Technology & Therapeutics, 10/16/09
Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results
Clinical Endocrinology, 10/15/09
Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis
Clinical Therapeutics, 10/15/09    Evidence Based Medicine
Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study
Diabetes Care, 10/14/09
Postprandial Vascular Effects of Viaject compared with Insulin Lispro and Regular Human Insulin in Patients with Type 2 Diabetes Mellitus
Diabetes Care, 10/14/09
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial)
Diabetes Care, 10/14/09
Short-term treatment with olanzapine does not modulate gut hormone secretion; olanzapine disintegrating vs standard tablets
European Journal of Endocrinology, 10/14/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more...
250 Available Pages
First    Prev    5      6      7      8      9      10      11      12      13      14      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.